Literature DB >> 9604851

Effects of certain resorcinol derivatives on the tyrosinase activity and the growth of melanoma cells.

K Tasaka1, C Kamei, S Nakano, Y Takeuchi, M Yamato.   

Abstract

Effects of certain resorcinol derivatives on tyrosinase activity, melanin formation and some other biological activities were studied in order to develop a new, potent depigmentor and/or antimelanoma drug. NKO-09, having isopentyl group in position 6 of resorcinal, exhibited a more potent effect than the compounds which have methyl (NKO-10), ethyl (NKO-11), hexyl (KOM-14), octyl (NKO-14), decyl (NKO-19), dodecyl (NKO-15) and tetradecyl (NKO-16) group in inhibiting the tyrosinase activities (both tyrosine hydroxylation and dopa oxidation). NKO-09 was more potent than hydroquinone in inhibiting the tyrosine hydroxylation; furthermore, NKO-09 inhibited the dopa oxidation different from hydroquinone. In the studies on melanin formation, protein synthesis and the growth of the melanoma cells, NKO-09 caused the most potent effect among the test compounds, except for the growth of the melanoma cells. KOM-14 was more potent than NKO-09 in the antimelanoma activity, and its effect was superior than that of 5-fluorouracil. From these findings, it is suggested that NKO-09 and KOM-14 can be used as an efficacious depigmentor and antimelanoma drug, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9604851     DOI: 10.1358/mf.1998.20.2.485637

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  7 in total

1.  Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.

Authors:  James H Herndon; Elizabeth T Makino; Thomas J Stephens; Rahul C Mehta
Journal:  J Clin Aesthet Dermatol       Date:  2014-05

2.  The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.

Authors:  Sun Young Huh; Jung-Won Shin; Jung-Im Na; Chang-Hun Huh; Sang-Woong Youn; Kyoung-Chan Park
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

3.  Novel vitamin E derivative with 4-substituted resorcinol moiety has both antioxidant and tyrosinase inhibitory properties.

Authors:  K Shimizu; R Kondo; K Sakai; N Takeda; T Nagahata; T Oniki
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

4.  The use of retinoic acid in association with microneedling in the treatment of epidermal melasma: efficacy and oxidative stress parameters.

Authors:  Clarissa L M da Silva Bergmann; Daniela Pochmann; Julio Bergmann; Fernanda Brasil Bocca; Isabel Proença; Jessica Marinho; Alexandre Mello; Caroline Dani
Journal:  Arch Dermatol Res       Date:  2020-09-25       Impact factor: 3.017

5.  Upregulation of Mitf by Phenolic Compounds-Rich Cymbopogon schoenanthus Treatment Promotes Melanogenesis in B16 Melanoma Cells and Human Epidermal Melanocytes.

Authors:  Myra O Villareal; Sayuri Kume; Mohamed Neffati; Hiroko Isoda
Journal:  Biomed Res Int       Date:  2017-11-21       Impact factor: 3.411

6.  Antidermatophytic Action of Resorcinol Derivatives: Ultrastructural Evidence of the Activity of Phenylethyl Resorcinol against Microsporum gypseum.

Authors:  Carlo Romagnoli; Anna Baldisserotto; Chiara B Vicentini; Donatella Mares; Elisa Andreotti; Silvia Vertuani; Stefano Manfredini
Journal:  Molecules       Date:  2016-09-30       Impact factor: 4.411

Review 7.  A comprehensive review on tyrosinase inhibitors.

Authors:  Samaneh Zolghadri; Asieh Bahrami; Mahmud Tareq Hassan Khan; J Munoz-Munoz; F Garcia-Molina; F Garcia-Canovas; Ali Akbar Saboury
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.